Literature DB >> 8444207

Involvement of the central nervous system in renal hypertension.

K Schärer1, C Benninger, A Heimann, W Rascher.   

Abstract

Involvement of the central nervous system (CNS) is a major complication of renal hypertension and is usually due to hypertensive encephalopathy. During a 17-year period we observed 25 children with renal hypertension associated with CNS manifestations in the absence of (group A) and 33 in the presence of advanced renal failure (group B). Convulsions were the most important symptom (65% in both groups combined). Other manifestations were reduced consciousness (69%), visual disturbances (28%), hemiplegia (14%), and cranial nerve palsy (10%). In 56% of children in group A, hypertension was recognised only after appearance of CNS symptoms. Three patients in group A and 19 in group B died. Intracranial haemorrhage associated with hemiplegia was found in 3 cases. From 1970-1977 to 1978-1986 the number of patients and the mortality in group B declined dramatically, probably as a result of improved antihypertensive and renal replacement therapy. In contrast, in group A the number of patients and of CNS symptoms remained similar. The study underlines the importance of frequent blood pressure monitoring in presence of acute or chronic renal disease.

Entities:  

Mesh:

Year:  1993        PMID: 8444207     DOI: 10.1007/bf02072518

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

Review 1.  Hypertension first seen as facial paralysis: case reports and review of the literature.

Authors:  R L Siegler; E D Brewer; H M Corneli; J A Thompson
Journal:  Pediatrics       Date:  1991-03       Impact factor: 7.124

Review 2.  Blood pressure and hypertension in childhood and adolescence.

Authors:  E P Leumann
Journal:  Ergeb Inn Med Kinderheilkd       Date:  1979

3.  Focal intracerebral oedema in hypertensive encephalopathy visualized by computerized tomographic scan.

Authors:  C M Jespersen; D Rasmussen; V Hennild
Journal:  J Intern Med       Date:  1989-05       Impact factor: 8.989

4.  Renovascular hypertension as a cause of cerebrovascular accident in childhood: a case report.

Authors:  D J Scholten; C Alberts; C J Snijders; A G Balk
Journal:  Neuropadiatrie       Date:  1977-08

5.  Hypertensive encephalopathy in childhood. Diagnostic problems.

Authors:  A J van Vught; J Troost; J Willemse
Journal:  Neuropadiatrie       Date:  1976-02

6.  Hypertensive encephalopathy. A cause of neonatal seizures.

Authors:  S Mace; S Hirschfeld
Journal:  Am J Dis Child       Date:  1983-01

7.  Blindness and paraplegia in severe childhood hypertension.

Authors:  J A Hulse; D S Taylor; M J Dillon
Journal:  Lancet       Date:  1979-09-15       Impact factor: 79.321

8.  Severe hypertensive retinopathy. Increased incidence in renoparenchymal hypertension.

Authors:  E Heidbreder; U Hüller; B Schäfer; A Heidland
Journal:  Am J Nephrol       Date:  1987       Impact factor: 3.754

9.  Hypertensive encephalopathy: a clinicopathologic study of 20 cases.

Authors:  E M Chester; D P Agamanolis; B Q Banker; M Victor
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

10.  Central nervous system involvement in severe arterial hypertension of childhood.

Authors:  M Uhari; A L Saukkonen; O Koskimies
Journal:  Eur J Pediatr       Date:  1979-11       Impact factor: 3.183

View more
  3 in total

1.  Posterior reversible encephalopathy syndrome in (low renin) essential hypertension.

Authors:  C M Everett; B Turner; M Lobo
Journal:  J R Soc Med       Date:  2007-11       Impact factor: 5.344

2.  A comparative study by retrograde neuronal tracing and substance P immunohistochemistry of sympathetic preganglionic neurons in spontaneously hypertensive rats and Wistar-Kyoto rats.

Authors:  F R Tang; C K Tan; E A Ling
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

3.  Mortality trends in pediatric patients with chronic renal failure.

Authors:  U Reiss; A M Wingen; K Schärer
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.